DNA-based nanostructures for RNA delivery
Author:
Wu Yuanyuan1, Luo Liangzhi2, Hao Ziyang2ORCID, Liu Dongsheng3
Affiliation:
1. Beijing SupraCirc Biotechnology Co., Ltd , Beijing , China 2. 12517 School of Pharmaceutical Sciences, Capital Medical University , Beijing , China 3. 12442 Department of Chemistry, Engineering Research Center of Advanced Rare Earth Materials, (Ministry of Education), Tsinghua University , Beijing , China
Abstract
Abstract
RNA-based therapeutics have emerged as a promising approach for the treatment of various diseases, including cancer, genetic disorders, and infectious diseases. However, the delivery of RNA molecules into target cells has been a major challenge due to their susceptibility to degradation and inefficient cellular uptake. To overcome these hurdles, DNA-based nano technology offers an unprecedented opportunity as a potential delivery platform for RNA therapeutics. Due to its excellent characteristics such as programmability and biocompatibility, these DNA-based nanostructures, composed of DNA molecules assembled into precise and programmable structures, have garnered significant attention as ideal building materials for protecting and delivering RNA payloads to the desired cellular destinations. In this review, we highlight the current progress in the design and application of three DNA-based nanostructures: DNA origami, lipid-nanoparticle (LNP) technology related to frame guided assembly (FGA), and DNA hydrogel for the delivery of RNA molecules. Their biomedical applications are briefly discussed and the challenges and future perspectives in this field are also highlighted.
Funder
Beijing Municipal Science & Technology Commission National Natural Science Foundation of China National Basic Research Plan of ChinaNational Natural Science Foundation of China
Publisher
Walter de Gruyter GmbH
Reference107 articles.
1. Rinoldi, C, Zargarian, SS, Nakielski, P, Li, X, Liguori, A, Petronella, F, et al.. Nanotechnology-assisted RNA delivery: from nucleic acid therapeutics to COVID-19 vaccines. Small Methods 2021;5:2100402. https://doi.org/10.1002/smtd.202100402. 2. Yu, Q, Qiu, Y, Wang, X, Tang, J, Liu, Y, Mei, L, et al.. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: a new preeclampsia-like mouse model. Int J Pharm 2018;546:115–24. https://doi.org/10.1016/j.ijpharm.2018.05.001. 3. Sinegra, AJ, Evangelopoulos, M, Park, J, Huang, Z, Mirkin, CA. Lipid nanoparticle spherical nucleic acids for intracellular DNA and RNA delivery. Nano Lett 2021;21:6584–91. https://doi.org/10.1021/acs.nanolett.1c01973. 4. KRAINER, MLHAR, Krainer, AR. RNA therapeutics. RNA 2023;29:393–5. https://doi.org/10.1261/rna.079626.123. 5. Yan, Y, Liu, X-Y, Lu, A, Wang, X-Y, Jiang, L-X, Wang, J-C. Non-viral vectors for RNA delivery. J Contr Release 2022;342:241–79. https://doi.org/10.1016/j.jconrel.2022.01.008.
|
|